Skip to main navigation Skip to search Skip to main content

Outcome measures in psoriatic arthritis

  • Dafna D. Gladman
  • , Philip J. Mease
  • , Paul Healy
  • , Philip S. Helliwell
  • , Oliver Fitzgerald
  • , Alberto Cauli
  • , Ennio Lubrano
  • , Gerald G. Krueger
  • , Désirée Van Der Heijde
  • , Douglas J. Veale
  • , Arthur Kavanaugh
  • , Peter Nash
  • , Christopher Ritchlin
  • , William Taylor
  • , Vibeke Strand

Research output: Contribution to journalArticlepeer-review

113 Scopus citations

Abstract

Psoriatic arthritis (PsA), an inflammatory arthritis associated with psoriasis usually seronegative for rheumatoid factor, has emerged as a more common and severe disease than previously appreciated. The disease is multifaceted. Thus the assessment of PsA requires attention to peripheral joint involvement, axial disease, dactylitis, and enthesitis, as well as the skin manifestations. In addition, the assessment of patient reported features such as patient assessment of disease activity, pain, fatigue, quality of life, and the new concept of participation are important. The assessment of damage and the assessment of tissue histology are also important outcome measures. This article summarizes these features of PsA as well as current knowledge on the instruments available for the assessment of these domains.

Original languageEnglish
Pages (from-to)1159-1166
Number of pages8
JournalJournal of Rheumatology
Volume34
Issue number5
StatePublished - May 2007

Keywords

  • Domains
  • Instruments
  • Outcome measures
  • Psoriatic arthritis

Fingerprint

Dive into the research topics of 'Outcome measures in psoriatic arthritis'. Together they form a unique fingerprint.

Cite this